Aspirin in the prevention of cardiovascular events in patients with diabetes.

about

Aspirin in the prevention of cardiovascular events in patients with diabetes.

Item

http://www.wikidata.org/entity/Q40225996

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Aspirin in the prevention of cardiovascular events in patients with diabetes.

@en

type

Item

label

Aspirin in the prevention of cardiovascular events in patients with diabetes.

@en

prefLabel

Aspirin in the prevention of cardiovascular events in patients with diabetes.

@en

P1476

Aspirin in the prevention of cardiovascular events in patients with diabetes.

@en

P2093

David S H Bell

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American Co

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

Prevalence of aspirin resistance in patients with type 2 diabetes

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

Low-dose aspirin for the prevention of atherothrombosis

P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation

P304

180-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2016.1131106

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26653848

http://www.w3.org/2001/XMLSchema#string

P921

aspirin